Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 1471 AL 1485

Trackins (Trk-Targeting Drugs): A Novel Therapy for Different Diseases

Chaldakov GN, Aloe L, Yanev SG, Fiore M, Tonchev AB, Vinciguerra M, Evtimov NT, Ghenev P, Dikranian K.

Pharmaceuticals (Basel). 2024 Jul 19;17(7):961. doi: 10.3390/ph17070961.

Potential Neuroprotective Effects of Alpinia officinarum Hance (Galangal): A Review

Abd Rahman IZ, Adam SH, Hamid AA, Mokhtar MH, Mustafar R, Kashim MIAM, Febriza A, Mansor NI.

Nutrients. 2024 Oct 4;16(19):3378. doi: 10.3390/nu16193378.

Navigating the nano-bio immune interface: advancements and challenges in CNS nanotherapeutics

Moulton C, Baroni A, Quagliarini E, Leone L, Digiacomo L, Morotti M, Caracciolo G, Podda MV, Tasciotti E.

Front Immunol. 2024 Nov 12;15:1447567. doi: 10.3389/fimmu.2024.1447567. eCollection 2024.

Well-known polypeptides of deer antler velvet with key actives: modern pharmacological advances

Sun H, Xiao D, Liu W, Li X, Lin Z, Li Y, Ding Y.

Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):15-31. doi: 10.1007/s00210-023-02642-y. Epub 2023 Aug 9.

Regulated Necrosis in Glaucoma: Focus on Ferroptosis and Pyroptosis

Chen D, Miao S, Chen X, Wang Z, Lin P, Zhang N, Yang N.

Mol Neurobiol. 2024 May;61(5):2542-2555. doi: 10.1007/s12035-023-03732-x. Epub 2023 Nov 1.

The Role of the Vascular System in Degenerative Diseases: Mechanisms and Implications

Sheikh AM, Yano S, Tabassum S, Nagai A.

Int J Mol Sci. 2024 Feb 11;25(4):2169. doi: 10.3390/ijms25042169.

Mesenchymal Stem Cell (MSC)-Based Drug Delivery into the Brain across the Blood-Brain Barrier

Tashima T.

Pharmaceutics. 2024 Feb 18;16(2):289. doi: 10.3390/pharmaceutics16020289.

Peptides derived from growth factors: Exploring their diverse impact from antimicrobial properties to neuroprotection

Hai-Na Z, Jun-Jie J, Guang-Meng X.

Biomed Pharmacother. 2024 Jul;176:116830. doi: 10.1016/j.biopha.2024.116830. Epub 2024 Jun 1.

MicroRNA-219 in the central nervous system: a potential theranostic approach

Shamaeizadeh N, Mirian M.

Res Pharm Sci. 2024 Dec 15;19(6):634-655. doi: 10.4103/RPS.RPS_163_23. eCollection 2024 Dec.

Two new cases with the UBQLN2 gene mutation in Han Chinese

He S, He XX, Yang HQ, Zhang JW, Chen S.

Neurol Sci. 2024 Oct;45(10):5047-5051. doi: 10.1007/s10072-024-07674-7. Epub 2024 Jun 28.

Comparison of Dentatorubrothalamic Tractography Methods Based on the Anatomy of the Rubral Wing

Berger A, Chung J, Schnurman Z, Stepanov V, Pan L, Shepherd TM, Mogilner A.

Oper Neurosurg. 2024 Jul 1;27(1):56-64. doi: 10.1227/ons.0000000000001058. Epub 2024 Jan 30.

Plasma lipidomic signatures of dementia with Lewy bodies revealed by machine learning, and compared to alzheimer's disease

Shen H, Yu Y, Wang J, Nie Y, Tang Y, Qu M.

Alzheimers Res Ther. 2024 Oct 15;16(1):226. doi: 10.1186/s13195-024-01585-7.

Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders

Yazdan Panah M, Vaheb S, Mokary Y, Afshari-Safavi A, Shaygannejad A, Ebrahimi N, Shaygannejad V, Mirmosayyeb O.

Vaccine. 2024 Oct 3;42(23):126061. doi: 10.1016/j.vaccine.2024.06.028. Epub 2024 Jun 16.

Comparison of the effectiveness, safety, and costs of anti-Parkinson drugs: A multiple-center retrospective study

Li W, Zhang H, Zhang Y, Wang K, Hui J, Yi Z.

CNS Neurosci Ther. 2024 Apr;30(4):e14531. doi: 10.1111/cns.14531. Epub 2023 Nov 20.

[Cognitive impairment in multiple system atrophy - exclusion criteria or an integral part of the clinical picture?]

Katunina EA, Shipilova NN, Farnieva IA, Isaeva ZS, Dzugaeva FK, Belikova LP, Batsoeva DO.

Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(4. Vyp. 2):86-91. doi: 10.17116/jnevro202412404286.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias